Many patients experience greater average weight loss with tirzepatide, although individual results can differ
With our commitment to personalized care, we aim to guide our patients through the intricacies of these treatments, highlighting their differences and benefits, and helping them make an informed decision about their health
Thats why it's essential to increase the dose gradually over several weeks, allowing a clinician to monitor how your body tolerates the medication
In clinical studies, the average weight loss was 15% and 20% with 77% of patients seeing sustained results for 2 years* *In a 68- and 72-week clinical trial studying Semaglutide in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)